Literature DB >> 19834810

Bacterial translocation to mesenteric lymph nodes increases in chronic portal hypertensive rats.

Miguel-Angel Llamas1, María-Angeles Aller, Domingo Marquina, María-Paz Nava, Jaime Arias.   

Abstract

PURPOSE: Bacterial translocation is a frequent complication in portal hypertension related to cirrhosis in the human clinical area. The aim of this study was to verify the existence of intestinal bacterial translocation to mesenteric lymph nodes in male Wistar rats with triple partial portal vein ligation during short- (48 h) and long-term (1 month) postoperative evolution.
RESULTS: At 48 h, ileal total aerobes bacteria (p < 0.001) and Lactobacillus decrease in sham-operated (SO) and portal hypertensive (PH) rats. At 1 month, ileal Enterococci and Streptococcus sp. show a statistically significant decrease in SO- and PH-rats. Lactobacillus decreases in the colon in SO- (p < 0.01) and in PH-rats (p < 0.001). At 1 month, colonic Enterococci decreases compared to control (p < 0.001) and SO-rats (p < 0.01). These intestinal microfloral changes are associated with bacterial translocation to mesenteric lymph nodes at 48 h (50%; p = 0.004) and 1 month (100%; p < 0.001) of postoperative evolution in PH-rats.
CONCLUSIONS: The enlargement of the stenosed portal tract related to triple partial portal vein ligation in the rat, since it increases the resistance to the portal blood flow, may be a key factor involved in one of the pathological consequences of portal hypertension, as is bacterial translocation to mesenteric lymph nodes.

Entities:  

Mesh:

Year:  2009        PMID: 19834810     DOI: 10.1007/s10620-009-1001-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  67 in total

Review 1.  Sociomicrobiology: the connections between quorum sensing and biofilms.

Authors:  Matthew R Parsek; E P Greenberg
Journal:  Trends Microbiol       Date:  2005-01       Impact factor: 17.079

2.  Prevention of portal hypertension and portosystemic shunts by early chronic administration of clonidine in conscious portal vein-stenosed rats.

Authors:  H C Lin; O Soubrane; D Lebrec
Journal:  Hepatology       Date:  1991-08       Impact factor: 17.425

3.  Bacterial translocation and intestinal morphological findings in jaundiced rats.

Authors:  Pierpaolo Sileri; Sergio Morini; Giuseppe S Sica; Stefano Schena; Cristiana Rastellini; Achille L Gaspari; Enrico Benedetti; Luca Cicalese
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

4.  Lipopolysaccharide modulation of normal enterocyte turnover by toll-like receptors is mediated by endogenously produced tumour necrosis factor alpha.

Authors:  F M Ruemmele; J F Beaulieu; S Dionne; E Levy; E G Seidman; N Cerf-Bensussan; M J Lentze
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

5.  Allopurinol reduces bacterial translocation, intestinal mucosal lipid peroxidation, and neutrophil-derived myeloperoxidase activity in chronic portal hypertensive and common bile duct-ligated growing rats.

Authors:  G Schimpl; P Pesendorfer; G Steinwender; G Feierl; M Ratschek; M E Höllwarth
Journal:  Pediatr Res       Date:  1996-09       Impact factor: 3.756

6.  Effects of different probiotic strains of Lactobacillus and Bifidobacterium on bacterial translocation and liver injury in an acute liver injury model.

Authors:  D Adawi; S Ahrné; G Molin
Journal:  Int J Food Microbiol       Date:  2001-11-08       Impact factor: 5.277

7.  Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats.

Authors:  F Y Lee; L A Colombato; A Albillos; R J Groszmann
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

8.  The association between enteric bacterial overgrowth and gastrointestinal motility after subtotal liver resection or portal vein obstruction in rats.

Authors:  X D Wang; W D Guo; Q Wang; R Andersson; E Ekblad; V Soltesz; S Bengmark
Journal:  Eur J Surg       Date:  1994-03

9.  Bacterial translocation in the portal-hypertensive rat: studies in basal conditions and on exposure to hemorrhagic shock.

Authors:  W T Sorell; E M Quigley; G Jin; T J Johnson; L F Rikkers
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

10.  Proinflammatory liver and antiinflammatory intestinal mediators involved in portal hypertensive rats.

Authors:  Maria Angeles Aller; Elena Vara; Cruz Garcia; Maria Dolores Palma; Jorge L Arias; Maria Paz Nava; Jaime Arias
Journal:  Mediators Inflamm       Date:  2005-06-09       Impact factor: 4.711

View more
  11 in total

1.  Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

Authors:  Georgios I Tsiaoussis; Stelios F Assimakopoulos; Athanassios C Tsamandas; Christos K Triantos; Konstantinos C Thomopoulos
Journal:  World J Hepatol       Date:  2015-08-18

2.  Gut-brain chemokine changes in portal hypertensive rats.

Authors:  Joaquin Merino; Maria-Angeles Aller; Sandra Rubio; Natalia Arias; Maria-Paz Nava; Maria Loscertales; Jaime Arias; Jorge-Luis Arias
Journal:  Dig Dis Sci       Date:  2011-02-24       Impact factor: 3.199

3.  Procalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites.

Authors:  Bashar M Attar; Christopher M Moore; Magdalena George; Nicolae Ion-Nedelcu; Rafael Turbay; Annamma Zachariah; Guiliano Ramadori; Jawed Fareed; David H Van Thiel
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 4.  Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.

Authors:  Yuji Nagatomo; W H Wilson Tang
Journal:  J Card Fail       Date:  2015-10-03       Impact factor: 5.712

5.  The interstitial lymphatic peritoneal mesothelium axis in portal hypertensive ascites: when in danger, go back to the sea.

Authors:  M A Aller; I Prieto; S Argudo; F de Vicente; L Santamaría; M P de Miguel; J L Arias; J Arias
Journal:  Int J Inflam       Date:  2010-10-05

6.  Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis.

Authors:  Tien Dong; Andrew Aronsohn; K Gautham Reddy; Helen S Te
Journal:  Dig Dis Sci       Date:  2016-09-21       Impact factor: 3.199

Review 7.  Exploring the Microbiome in Heart Failure.

Authors:  Takeshi Kitai; Jennifer Kirsop; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2016-04

Review 8.  Splanchnic-aortic inflammatory axis in experimental portal hypertension.

Authors:  Maria-Angeles Aller; Natalia de las Heras; Maria-Paz Nava; Javier Regadera; Jaime Arias; Vicente Lahera
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

9.  Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis.

Authors:  Mingyue Yang; Wenxiu Jia; Dong Wang; Fei Han; Weiwei Niu; Hong Zhang; David Q Shih; Xiaolan Zhang
Journal:  Dig Dis Sci       Date:  2019-04-04       Impact factor: 3.487

Review 10.  The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Jaime Arias
Journal:  J Transl Med       Date:  2007-09-24       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.